The invention is concerned with cyclic amines of formula (I)
wherein X
1
to X
3
, Y
1
to Y
3
, R
1′
, R
1″
and n are as defined in the description and in the claims, as well as physiologically acceptable salts thereof. These compounds inhibit coagulation factor Xa and can be used as medicaments and for treating diseases associated with coagulation factor Xa.
α-Substituted <i>N</i>-(Sulfonamido)alkyl-β-aminotetralins: Potent and Selective Neuropeptide Y Y5 Receptor Antagonists
作者:Mark A. Youngman、James J. McNally、Timothy W. Lovenberg、Allen B. Reitz、Nicole M. Willard、Diane H. Nepomuceno、Sandy J. Wilson、Jeffrey J. Crooke、Daniel Rosenthal、Anil H. Vaidya、Scott L. Dax